(Q33392397)

English

Association of increased serum IL-33 levels with clinical and laboratory characteristics of systemic lupus erythematosus in Chinese population

scientific article published on October 21, 2010

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Association of increased serum IL-33 levels with clinical and laboratory characteristics of systemic lupus erythematosus in Chinese population (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

systemic lupus erythematosus

1 reference

based on heuristic

inferred from title

author name string

Zaixing Yang

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Yan Liang

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Weiqiang Xi

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Chang Li

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Renqian Zhong

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20963466

6 August 2024

publication date

21 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

full work available at URL

http://link.springer.com/content/pdf/10.1007/s10238-010-0115-4.pdf

Portable Document Format

1 reference

10.1007/S10238-010-0115-4

https://api.crossref.org/works/10.1007/S10238-010-0115-4

6 August 2024

http://link.springer.com/article/10.1007/s10238-010-0115-4/fulltext.html

1 reference

10.1007/S10238-010-0115-4

https://api.crossref.org/works/10.1007/S10238-010-0115-4

6 August 2024

http://link.springer.com/content/pdf/10.1007/s10238-010-0115-4

1 reference

10.1007/S10238-010-0115-4

https://api.crossref.org/works/10.1007/S10238-010-0115-4

6 August 2024

Clinical and Experimental Medicine

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

75-80

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Systemic lupus erythematosus: multiple immunological phenotypes in a complex genetic disease.

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0115-4

21 January 2018

Molecular aberrations in human systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0115-4

21 January 2018

Systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0115-4

21 January 2018

The role of extracellular DNA in autoimmunity in SLE.

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0115-4

21 January 2018

Update on the epidemiology of systemic lupus erythematosus: new spins on old ideas

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0115-4

21 January 2018

IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0115-4

21 January 2018

Characterization of signaling pathways activated by the interleukin 1 (IL-1) receptor homologue T1/ST2. A role for Jun N-terminal kinase in IL-4 induction.

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0115-4

21 January 2018

IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0115-4

21 January 2018

The biological and clinical importance of the 'new generation' cytokines in rheumatic diseases

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0115-4

21 January 2018

IL-33 exacerbates antigen-induced arthritis by activating mast cells

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0115-4

21 January 2018

IL-33 reduces the development of atherosclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0115-4

21 January 2018

IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells.

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0115-4

21 January 2018

Th1/Th2 cytokines in patients with systemic lupus erythematosus: is tumor necrosis factor alpha protective?

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0115-4

21 January 2018

How the study of children with rheumatic diseases identified interferon-alpha and interleukin-1 as novel therapeutic targets

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0115-4

21 January 2018

Tumour necrosis factor and other proinflammatory cytokines in systemic lupus erythematosus: a rationale for therapeutic intervention

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0115-4

21 January 2018

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0115-4

21 January 2018

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0115-4

21 January 2018

Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0115-4

21 January 2018

Serum levels of IL-33 and soluble ST2 and their association with disease activity in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0115-4

21 January 2018

Incidence of systemic lupus erythematosus. Race and gender differences

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0115-4

21 January 2018

Mortality in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0115-4

21 January 2018

Differences in subclinical cardiovascular disease between African American and Caucasian women with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0115-4

21 January 2018

Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33.

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0115-4

21 January 2018

European population substructure is associated with mucocutaneous manifestations and autoantibody production in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0115-4

21 January 2018

Clinical significance of IgA anticardiolipin and anti-beta2-GP1 antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0115-4

21 January 2018

IL-33 can promote survival, adhesion and cytokine production in human mast cells

1 reference

https://api.crossref.org/works/10.1007%2FS10238-010-0115-4

21 January 2018

Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20963466

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survival in systemic lupus erythematosus. A multivariate analysis of demographic factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/20963466

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The increased interleukin-13 in patients with systemic lupus erythematosus: relations to other Th1-, Th2-related cytokines and clinical findings

1 reference

https://pubmed.ncbi.nlm.nih.gov/20963466

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

C1q inhibits immune complex-induced interferon-alpha production in plasmacytoid dendritic cells: a novel link between C1q deficiency and systemic lupus erythematosus pathogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20963466

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genetic susceptibility to systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/20963466

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The American College of Rheumatology response criteria for proliferative and membranous renal disease in systemic lupus erythematosus clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/20963466

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transgene-mediated hyper-expression of IL-5 inhibits autoimmune disease but increases the risk of B cell chronic lymphocytic leukemia in a model of murine lupus

1 reference

https://pubmed.ncbi.nlm.nih.gov/20963466

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cutting edge: The ST2 ligand IL-33 potently activates and drives maturation of human mast cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/20963466

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High prevalence of immunoglobulin A antibody against Epstein-Barr virus capsid antigen in adult patients with lupus with disease flare: case control studies.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20963466

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High circulating levels of free interleukin-18 in patients with active SLE in the presence of elevated levels of interleukin-18 binding protein

1 reference

https://pubmed.ncbi.nlm.nih.gov/20963466

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Journal of Rheumatology

36

32

44

author name string

C Chen

publication date

2005

1 reference

10.1007/S10238-010-0115-4

https://api.crossref.org/works/10.1007/S10238-010-0115-4

6 August 2024

Identifiers

10.1007/S10238-010-0115-4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33392397&oldid=2222251834"